Labcorp to Speak at the Morgan Stanley 24th Annual Global Healthcare Conference
Get Alerts LH Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 0.9%
Revenue Growth %: +5.3%
Join SI Premium – FREE
A live audio webcast of the fireside chat will be available via the Labcorp Investor Relations website at ir.labcorp.com and archived for replay for 180 days following the event.
About Labcorp
Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's nearly 71,000 employees serve clients in approximately 100 countries, provided support for more than 85% of the new drugs and therapeutic products approved by the FDA in 2025 and performed more than 750 million tests for patients around the world. Learn more at www.labcorp.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/labcorp-to-speak-at-the-morgan-stanley-24th-annual-global-healthcare-conference-302862314.html
SOURCE Labcorp Holdings Inc
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Last-Minute Gift Delivery (2026): Same-Day Ideas for Birthdays, Flowers, and Small Gifts by Expert Consumers
- Frost & Sullivan Appoints Janesh Janardhanan as Global Partner and Head of Subscriptions
- Socify.ai Surges to 300 Clients, Emerging as a Fast-Growing Challenger in AI-Powered SOC 2 Compliance
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Morgan Stanley, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share